Market Realist on MSN

How Colossal Biosciences uses CRISPR and the safeguards behind the science

Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...
Forbes

CRISPR: From Discovery To Clinic—And Charting A Path Forward

In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...